A randomized, open trial evaluating the effect of <i>Saccharomyces boulardii</i> on the eradication rate of <i>Helicobacter pylori</i> infection in children

Abstract

The addition of S. boulardii to the standard eradication treatment confers a 12% nonsignificant enhanced therapeutic benefit on H. pylori eradication and reduces significantly the incidence of side effects.